or Try an Advanced Search...

    Technical Analysis for NEXI - NexImmune, Inc.

    Grade Last Price % Change Price Change
    F 2.58 -6.55% -0.18
    NEXI closed down 6.55 percent on Monday, July 1, 2024, on 2.02 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NEXI trend table...
    Date Alert Name Type % Chg
    Expansion Breakdown Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Lower Bollinger Band Touch Weakness -6.55%
    Stochastic Reached Oversold Weakness -4.48%
    Oversold Stochastic Weakness -4.48%
    Outside Day Range Expansion -6.55%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.89%
    Inside Day Range Contraction -7.89%
    Older End-of-Day Signals for NEXI ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 10 hours ago
    1.5x Volume Pace about 10 hours ago
    3x Volume Pace about 10 hours ago
    10x Volume Pace about 10 hours ago
    5x Volume Pace about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NEXI Chart by TradingView
    Basic chart:

    Profile

    NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIM) technology. The company has two product candidates in human trials, including NEXI-001 in acute myeloid leukemia, or AML; and NEXI-002 in multiple myeloma, or MM. NexImmune, Inc. was founded in 2011 and is headquartered in Gaithersburg, Maryland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Acute Myeloid Leukemia Immunotherapies Leukemia Multiple Myeloma Immune Mediated Diseases

    Is NEXI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 7 Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 6 NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Feb 2 NexImmune slips after securities offering
    Feb 2 NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Jan 9 Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Jan 8 Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Jan 4 Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    See more NEXI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.6949
    52 Week Low 1.2501
    Average Volume 12,337
    200-Day Moving Average 4.80
    50-Day Moving Average 3.15
    20-Day Moving Average 2.88
    10-Day Moving Average 2.77
    Average True Range 0.20
    RSI (14) 34.21
    ADX 22.59
    +DI 8.33
    -DI 28.02
    Chandelier Exit (Long, 3 ATRs) 2.64
    Chandelier Exit (Short, 3 ATRs) 2.95
    Upper Bollinger Bands 3.21
    Lower Bollinger Band 2.55
    Percent B (%b) 0.04
    BandWidth 22.91
    MACD Line -0.16
    MACD Signal Line -0.16
    MACD Histogram 0.0017
    Fundamentals Value
    Market Cap 3.36 Million
    Num Shares 1.3 Million
    EPS -42.05
    Price-to-Earnings (P/E) Ratio -0.06
    Price-to-Sales 0.00
    Price-to-Book 1.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.04
    Resistance 3 (R3) 3.02 2.83 2.97
    Resistance 2 (R2) 2.83 2.71 2.85 2.94
    Resistance 1 (R1) 2.71 2.64 2.77 2.73 2.91
    Pivot Point 2.52 2.52 2.55 2.54 2.52
    Support 1 (S1) 2.40 2.40 2.46 2.42 2.24
    Support 2 (S2) 2.21 2.33 2.23 2.22
    Support 3 (S3) 2.09 2.21 2.19
    Support 4 (S4) 2.11